ELI LILLY & Co
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1410.99−6.55 (-0.46%)
Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%
Eli Lilly Long-lived assets — Ireland by Year
Long-lived assets — Ireland ($M) ($M)
Eli Lilly Long-lived assets — Ireland: $4,321M in FY2025, up 34.8% from a year earlier. That is the highest of the 8 years on record here.
Latest, FY2025
4,321
Period ended Dec 31, 2025
Change on a year earlier
+34.8%
3,205 in FY2024
History
8 years
Since FY2018
Sources
7
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-12) ↗
Reported in Form 10-K Geographic Information Note.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Long-lived assets — Ireland ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4,321 | +34.8% | Form 10-K (filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | 3,205 | +17.7% | Form 10-K (filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 2,723 | +43.4% | Form 10-K (filed 2025-02-19) ↗ |
| FY2022 | Dec 31, 2022 | 1,899 | +11.5% | Form 10-K (filed 2024-02-21) ↗ |
| FY2021 | Dec 31, 2021 | 1,702 | -4.7% | Form 10-K (filed 2023-02-22) ↗ |
| FY2020 | Dec 31, 2020 | 1,787 | +22.8% | Form 10-K (filed 2022-02-23) ↗ |
| FY2019 | Dec 31, 2019 | 1,455 | +7.7% | Form 10-K (filed 2021-02-17) ↗ |
| FY2018 | Dec 31, 2018 | 1,351 | – | Form 10-K (filed 2020-02-19) ↗ |
Cite this data
StockData. (2026). Eli Lilly Long-lived assets — Ireland ($M), annual FY2018–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/geo-lla-ireland
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.